221 related articles for article (PubMed ID: 4548704)
1. Therapeutic freedom.
Trout ME
J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704
[No Abstract] [Full Text] [Related]
2. Labeling regulations: 'prescribe as directed'.
Regier H
J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
[No Abstract] [Full Text] [Related]
3. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
Willig SH
Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
[No Abstract] [Full Text] [Related]
4. Keeping prescription drugs safe and effective.
Bryan PA
Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
[No Abstract] [Full Text] [Related]
5. Instrument of impediment. The regulatory monograph in medical communications.
Archer J
J Kans Med Soc; 1972 Aug; 73(8):385-8. PubMed ID: 5068010
[No Abstract] [Full Text] [Related]
6. Drug substitution--boon to consumers versus legal trap for the professional.
Brennan BJ
J Leg Med (N Y); 1976 Mar; 4(3):20-5. PubMed ID: 1083405
[No Abstract] [Full Text] [Related]
7. The control of drugs and therapeutic freedom.
Dunlop D
Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
[No Abstract] [Full Text] [Related]
8. The medico-legal aspects of drug interactions.
Goldstein EM
J Forensic Sci; 1973 Oct; 18(4):335-43. PubMed ID: 4784302
[No Abstract] [Full Text] [Related]
9. [The doctor's responsibility and risk in the prescribing of drugs].
Aschenbrenner R
Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
[No Abstract] [Full Text] [Related]
10. Bill may curb physician's right to prescribe.
Harvey MW; Keller SE
Leg Aspects Med Pract; 1978 Sep; 6(9):27-30. PubMed ID: 750818
[No Abstract] [Full Text] [Related]
11. The doctor, the pharmacist, the patient, and the placebo, or you're not my mother, doctor.
Nielsen JR
Food Drug Cosmet Law J; 1989 Nov; 44(6):639-57. PubMed ID: 11659226
[No Abstract] [Full Text] [Related]
12. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
[No Abstract] [Full Text] [Related]
13. Federal drug laws and CRNAs.
Blumenreich GA; Stallone DR; Tobin MH
AANA J; 1990 Aug; 58(4):253-4. PubMed ID: 2399777
[No Abstract] [Full Text] [Related]
14. View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior.
Appler WD; McMann GL
J Clin Psychopharmacol; 1989 Oct; 9(5):368-70. PubMed ID: 2794099
[No Abstract] [Full Text] [Related]
15. Notes on the package insert.
JAMA; 1969 Feb; 207(7):1335-8. PubMed ID: 5818325
[No Abstract] [Full Text] [Related]
16. The medicolegal aspects of adverse drug reactions.
Bernstein HN; Levine AM
Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
[No Abstract] [Full Text] [Related]
17. Private rights to adulterated/misbranded articles.
McMonagle L
AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
[No Abstract] [Full Text] [Related]
18. How does the FDA affect you and your practice?
Novitch M
Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685
[No Abstract] [Full Text] [Related]
19. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
20. [Problems connected with the drug provision in the United States].
Sloot HA
Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
